Nyxoah S A (NYXH)

$7.46 -0.03 (-0.40%)
Market Cap 255.11M
Revenue (ttm) 4.89M
Net Income (ttm) -64.10M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,310.84%
Debt to Equity Ratio 0.20
Volume 67,400
Avg Vol 55,274
Day's Range N/A - N/A
Shares Out 34.06M
Stochastic %K 59%
Beta 1.61
Analysts Strong Sell
Price Target $12.75

Company Profile

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 32 1 022 23 55
Fax: 32 1 045 90 75
Address:
Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium
Fortcharles66
Fortcharles66 Aug. 3 at 5:22 PM
$NYXH - What is everyone’s opinion on stock price if we get FDA approval?
2 · Reply
KingTut
KingTut Jul. 31 at 12:13 PM
$NYXH it prob will. but the no beard thing is a big deal. and the battery is huge.. why does it need such a large battery.. putting it on under on chin every night like gets irritating. and the potential of knocking it loose is there.. at least it seems. the MRI and pacemaker limitations are a bit scary. i guess its meant for severe apnea sufferers.
1 · Reply
Muddymac
Muddymac Jul. 31 at 2:09 AM
$NYXH Added 3500 more shares.
0 · Reply
Muddymac
Muddymac Jul. 29 at 2:41 PM
$NYXH If anyone wants a deeper dive into Genio vs Inspire. Once approved, there’s no doubt Genio will start taking market share. https://youtu.be/cmOr5cpmljM?si=DlrnCoVjgJPXY2lO
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 29 at 12:41 PM
$NYXH (+6.0% pre) Nyxoah’s DREAM Study Data Published, Highlighting Genio® System’s Efficacy https://ooc.bz/l/71641
0 · Reply
coletrain89
coletrain89 Jul. 29 at 11:49 AM
$NYXH hmmmmm
0 · Reply
Frankie95
Frankie95 Jul. 28 at 11:36 AM
$NYXH junk
1 · Reply
EOSE_Investor
EOSE_Investor Jul. 21 at 10:35 PM
$NYXH
0 · Reply
Frankie95
Frankie95 Jul. 21 at 3:13 PM
$NYXH Still no update......
1 · Reply
KingTut
KingTut Jul. 20 at 4:11 PM
$NYXH $INSP ok I read enough to say yes. Can someone summarize the shelf offering? What have they issues as yet and at what price ?
0 · Reply
Latest News on NYXH
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 29, 2025, 4:30 PM EDT - 7 days ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jul 28, 2025, 4:05 PM EDT - 8 days ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Jun 13, 2025, 1:00 AM EDT - 7 weeks ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 4:30 PM EDT - 2 months ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

Nyxoah SA (NYXH) Q1 2025 Earnings Call Transcript

May 14, 2025, 2:35 PM EDT - 2 months ago

Nyxoah SA (NYXH) Q1 2025 Earnings Call Transcript

Nyxoah Reports First Quarter Financial and Operating Results

May 14, 2025, 1:00 AM EDT - 2 months ago

Nyxoah Reports First Quarter Financial and Operating Results

Publication relating to transparency notifications

May 9, 2025, 4:30 PM EDT - 3 months ago

Publication relating to transparency notifications

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

May 9, 2025, 1:00 AM EDT - 3 months ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Apr 22, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Apr 21, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 20, 2025, 10:00 AM EDT - 3 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Apr 18, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Apr 17, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Apr 16, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Conditional Issuance of Shares

Apr 16, 2025, 2:00 AM EDT - 3 months ago

Conditional Issuance of Shares

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Apr 15, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 14, 2025, 10:00 AM EDT - 4 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Apr 11, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 10, 2025, 10:00 AM EDT - 4 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Apr 9, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Apr 8, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Apr 8, 2025, 1:00 AM EDT - 4 months ago

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

Apr 7, 2025, 3:00 PM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Apr 7, 2025, 9:33 AM EDT - 4 months ago

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

Mar 31, 2025, 5:40 PM EDT - 4 months ago

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A.

Mar 31, 2025, 2:45 PM EDT - 4 months ago

Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A.

FDA Issues Nyxoah an Approvable Letter for its Genio® System

Mar 26, 2025, 3:00 AM EDT - 4 months ago

FDA Issues Nyxoah an Approvable Letter for its Genio® System

Nyxoah SA (NYXH) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 4:45 PM EDT - 5 months ago

Nyxoah SA (NYXH) Q4 2024 Earnings Call Transcript

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

Mar 13, 2025, 2:00 AM EDT - 5 months ago

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

Mar 10, 2025, 5:05 PM EDT - 5 months ago

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Mar 3, 2025, 4:30 PM EST - 5 months ago

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

Feb 19, 2025, 1:05 AM EST - 5 months ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

Nyxoah: The Future Of OSA

Dec 30, 2024, 4:01 AM EST - 7 months ago

Nyxoah: The Future Of OSA

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Dec 13, 2024, 2:05 AM EST - 8 months ago

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 9 months ago

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024

Nov 19, 2024, 1:00 AM EST - 9 months ago

Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024

Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 6:46 PM EST - 9 months ago

Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript

Nyxoah Appoints John Landry as Chief Financial Officer

Nov 4, 2024, 4:45 PM EST - 9 months ago

Nyxoah Appoints John Landry as Chief Financial Officer

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Oct 22, 2024, 4:30 PM EDT - 10 months ago

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Nyxoah Raises $27 Million through its At-the-Market Offering

Oct 7, 2024, 5:00 PM EDT - 10 months ago

Nyxoah Raises $27 Million through its At-the-Market Offering

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update

Sep 27, 2024, 4:30 PM EDT - 11 months ago

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update

Nyxoah to Participate in Upcoming Investor Conferences

Sep 5, 2024, 4:30 PM EDT - 11 months ago

Nyxoah to Participate in Upcoming Investor Conferences

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Sep 2, 2024, 4:05 PM EDT - 1 year ago

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Nyxoah S.A. (NYXH) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 1:44 AM EDT - 1 year ago

Nyxoah S.A. (NYXH) Q2 2024 Earnings Call Transcript

Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results

Fortcharles66
Fortcharles66 Aug. 3 at 5:22 PM
$NYXH - What is everyone’s opinion on stock price if we get FDA approval?
2 · Reply
KingTut
KingTut Jul. 31 at 12:13 PM
$NYXH it prob will. but the no beard thing is a big deal. and the battery is huge.. why does it need such a large battery.. putting it on under on chin every night like gets irritating. and the potential of knocking it loose is there.. at least it seems. the MRI and pacemaker limitations are a bit scary. i guess its meant for severe apnea sufferers.
1 · Reply
Muddymac
Muddymac Jul. 31 at 2:09 AM
$NYXH Added 3500 more shares.
0 · Reply
Muddymac
Muddymac Jul. 29 at 2:41 PM
$NYXH If anyone wants a deeper dive into Genio vs Inspire. Once approved, there’s no doubt Genio will start taking market share. https://youtu.be/cmOr5cpmljM?si=DlrnCoVjgJPXY2lO
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 29 at 12:41 PM
$NYXH (+6.0% pre) Nyxoah’s DREAM Study Data Published, Highlighting Genio® System’s Efficacy https://ooc.bz/l/71641
0 · Reply
coletrain89
coletrain89 Jul. 29 at 11:49 AM
$NYXH hmmmmm
0 · Reply
Frankie95
Frankie95 Jul. 28 at 11:36 AM
$NYXH junk
1 · Reply
EOSE_Investor
EOSE_Investor Jul. 21 at 10:35 PM
$NYXH
0 · Reply
Frankie95
Frankie95 Jul. 21 at 3:13 PM
$NYXH Still no update......
1 · Reply
KingTut
KingTut Jul. 20 at 4:11 PM
$NYXH $INSP ok I read enough to say yes. Can someone summarize the shelf offering? What have they issues as yet and at what price ?
0 · Reply
KingTut
KingTut Jul. 20 at 3:54 PM
$NYXH ok cole I followed you from aspi. Researching nyxh . Is $INSP considered a competitor ?
1 · Reply
coletrain89
coletrain89 Jul. 17 at 12:27 PM
$NYXH it has to be any day now.
0 · Reply
Muddymac
Muddymac Jul. 16 at 5:02 PM
$NYXH Should hopefully get FDA approval before August. Let’s go.
0 · Reply
coletrain89
coletrain89 Jul. 15 at 2:09 AM
$NYXH tick tock on the clock is painful
0 · Reply
Frankie95
Frankie95 Jul. 11 at 1:34 PM
$NYXH never seen a company with less interest in their investors. zero updates ever.
0 · Reply
coletrain89
coletrain89 Jul. 7 at 12:42 PM
$NYXH maybe news this week
0 · Reply
TheGodsMustBeCrazy
TheGodsMustBeCrazy Jul. 7 at 12:09 AM
$NYXH This month
0 · Reply
coletrain89
coletrain89 Jun. 28 at 7:19 PM
$NYXH what’s up fam . Just stumbled into this room. Does anybody know where the front desk is to check in for the rocket launch ? 🚀
0 · Reply
TheGodsMustBeCrazy
TheGodsMustBeCrazy Jun. 25 at 2:09 AM
$NYXH over the next few months they probably get fda approval. stock likely doubles or more on that news.
0 · Reply
sem18
sem18 Jun. 17 at 10:54 AM
$NYXH Immuneering Corporation (IMRX) announced it will host a conference call and webcast on June 17, 2025, at 8:00 am ET to provide updates from its ongoing Phase 2a clinical trial of IMM-1-104 in first-line pancreatic cancer patients. The webcast will be available live and archived in the company's Investor Relations section on their website. Immuneering, a clinical-stage oncology company, focuses on developing treatments to help cancer patients outlive their disease.
0 · Reply
TheGodsMustBeCrazy
TheGodsMustBeCrazy Jun. 17 at 12:04 AM
$NYXH If they get FDA approval in the next 30-90 days, which is very likely, this should be worth at least $1B (INSPIRE has a several billion dollar market cap and is an inferior product), ie 26.7/share. That's ~345% the current price.
1 · Reply
TheGodsMustBeCrazy
TheGodsMustBeCrazy Jun. 12 at 6:57 PM
$NYXH
0 · Reply